Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nephros (NEPH) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Nephros (NEPH) over the last 8 years, with Q3 2025 value amounting to $11.0 million.

  • Nephros' Shares Outstanding (Diluted Average) rose 434.76% to $11.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.0 million, marking a year-over-year increase of 434.76%. This contributed to the annual value of $10.6 million for FY2024, which is 207.96% up from last year.
  • Latest data reveals that Nephros reported Shares Outstanding (Diluted Average) of $11.0 million as of Q3 2025, which was up 434.76% from $10.8 million recorded in Q2 2025.
  • Over the past 5 years, Nephros' Shares Outstanding (Diluted Average) peaked at $11.0 million during Q3 2025, and registered a low of $10.3 million during Q4 2022.
  • Over the past 4 years, Nephros' median Shares Outstanding (Diluted Average) value was $10.5 million (recorded in 2023), while the average stood at $10.5 million.
  • As far as peak fluctuations go, Nephros' Shares Outstanding (Diluted Average) fell by 1.67% in 2023, and later skyrocketed by 434.76% in 2025.
  • Over the past 4 years, Nephros' Shares Outstanding (Diluted Average) (Quarter) stood at $10.3 million in 2022, then rose by 0.86% to $10.4 million in 2023, then rose by 2.08% to $10.6 million in 2024, then increased by 4.14% to $11.0 million in 2025.
  • Its last three reported values are $11.0 million in Q3 2025, $10.8 million for Q2 2025, and $10.6 million during Q1 2025.